Lv4
780 积分 2021-04-26 加入
Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia Treatment
1个月前
已完结
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study
2个月前
已完结
Tailored approaches in mantle cell lymphoma: refining treatment paradigms with an expert panel opinion
2个月前
已完结
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
2个月前
已完结
中国高危人群乙型肝炎病毒再激活防治指南(2026年版)
3个月前
已完结
New BTK Inhibitors May Combat Resistance in CLL
3个月前
已完结
Anlotinib in progressive RAI-refractory differentiated thyroid cancer: long-term results and PET/CT prognostic markers
3个月前
已完结
Hitting the Therapeutic Bullseye with Targeted Therapy for Patients with Chronic Lymphocytic Leukemia
3个月前
已完结
The tumour microenvironment in B cell lymphomas
5个月前
已完结
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
6个月前
已完结
皖公网安备34019202002308
